These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1144440)

  • 41. Effect of P-glycoprotein-mediated efflux on cerebrospinal fluid concentrations in rhesus monkeys.
    Tang C; Kuo Y; Pudvah NT; Ellis JD; Michener MS; Egbertson M; Graham SL; Cook JJ; Hochman JH; Prueksaritanont T
    Biochem Pharmacol; 2009 Sep; 78(6):642-7. PubMed ID: 19481060
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cerebrospinal fluid levels of 2'-deoxycoformycin after systemic administration in monkeys.
    Blatt J; Venner PM; Riccardi R; Cohen LF; Gangji D; Glazer RI; Poplack DG
    J Natl Cancer Inst; 1982 Mar; 68(3):391-3. PubMed ID: 6977672
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A phase I-II trial of multiple-dose polyriboinosic-polyribocytidylic acid in patieonts with leukemia or solid tumors.
    Robinson RA; DeVita VT; Levy HB; Baron S; Hubbard SP; Levine AS
    J Natl Cancer Inst; 1976 Sep; 57(3):599-602. PubMed ID: 978771
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Temporal analysis of blood-brain barrier disruption and cerebrospinal fluid matrix metalloproteinases in rhesus monkeys subjected to transient ischemic stroke.
    Zhang Y; Fan F; Zeng G; Zhou L; Zhang Y; Zhang J; Jiao H; Zhang T; Su D; Yang C; Wang X; Xiao K; Li H; Zhong Z
    J Cereb Blood Flow Metab; 2017 Aug; 37(8):2963-2974. PubMed ID: 27885100
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A clearance system for prostaglandin D2, a sleep-promoting factor, in cerebrospinal fluid: role of the blood-cerebrospinal barrier transporters.
    Tachikawa M; Tsuji K; Yokoyama R; Higuchi T; Ozeki G; Yashiki A; Akanuma S; Hayashi K; Nishiura A; Hosoya K
    J Pharmacol Exp Ther; 2012 Dec; 343(3):608-16. PubMed ID: 22931759
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasma and cerebrospinal fluid pharmacokinetics of the histone deacetylase inhibitor, belinostat (PXD101), in non-human primates.
    Warren KE; McCully C; Dvinge H; Tjørnelund J; Sehested M; Lichenstein HS; Balis FM
    Cancer Chemother Pharmacol; 2008 Aug; 62(3):433-7. PubMed ID: 17960383
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical studies of interferon. II. Recovery of interferon from cerebrospinal fluid of patients with aseptic meningitis.
    Kozaki T
    Nagoya J Med Sci; 1969 Jul; 32(1):121-7. PubMed ID: 5347820
    [No Abstract]   [Full Text] [Related]  

  • 48. [Distribution of human interferon in organs and tissues after its administration to man and animals].
    Maiakova SA; Berulava II; Gavrilova IE; Kuznetsov VP
    Vopr Virusol; 1980; (5):594-6. PubMed ID: 6159738
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 17 beta-estradiol levels in blood and cerebrospinal fluid after ocular and nasal administration in women and female rhesus monkeys (Macaca mulatta).
    Ohman L; Hahnenberger R; Johansson ED
    Contraception; 1980 Oct; 22(4):349-58. PubMed ID: 7449383
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metabolism of interferon: hepatic clearance of native and desialylated interferon.
    Bocci V; Pacini A; Pessina GP; Bargigli V; Russi M
    J Gen Virol; 1977 Jun; 35(3):525-34. PubMed ID: 881617
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Distribution of interferon in body fluids and tissues.
    Bocci V
    Tex Rep Biol Med; 1977; 35():436-42. PubMed ID: 358467
    [No Abstract]   [Full Text] [Related]  

  • 52. Delta sleep-inducing peptide crosses the blood-brain-barrier in dogs: some correlations with protein binding.
    Banks WA; Kastin AJ; Coy DH
    Pharmacol Biochem Behav; 1982 Nov; 17(5):1009-14. PubMed ID: 6897451
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of cationic drug-sensitive transport systems at the blood-cerebrospinal fluid barrier in para-tyramine elimination from rat brain.
    Akanuma SI; Yamazaki Y; Kubo Y; Hosoya KI
    Fluids Barriers CNS; 2018 Jan; 15(1):1. PubMed ID: 29307307
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Zidovudine concentration in brain extracellular fluid measured by microdialysis: steady-state and transient results in rhesus monkey.
    Fox E; Bungay PM; Bacher J; McCully CL; Dedrick RL; Balis FM
    J Pharmacol Exp Ther; 2002 Jun; 301(3):1003-11. PubMed ID: 12023531
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Penetration of phenylacetic acid across the blood-cerebrospinal fluid barrier.
    Pedemonte WA; Mosnaim AD; Bulat M
    Res Commun Chem Pathol Pharmacol; 1976 May; 14(1):111-6. PubMed ID: 935645
    [TBL] [Abstract][Full Text] [Related]  

  • 56. T3 may be a better agent than T4 in the critically ill hypothyroid patient: evaluation of transport across the blood-brain barrier in a primate model.
    Chernow B; Burman KD; Johnson DL; McGuire RA; O'Brian JT; Wartofsky L; Georges LP
    Crit Care Med; 1983 Feb; 11(2):99-104. PubMed ID: 6822088
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cerebrospinal fluid indices of blood-brain barrier permeability following adrenal-brain transplantation in patients with Parkinson's disease.
    Ahlskog JE; Tyce GM; Kelly PJ; van Heerden JA; Stoddard SL; Carmichael SW
    Exp Neurol; 1989 Aug; 105(2):152-61. PubMed ID: 2753115
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Penetration and distribution of gadolinium-based contrast agents into the cerebrospinal fluid in healthy rats: a potential pathway of entry into the brain tissue.
    Jost G; Frenzel T; Lohrke J; Lenhard DC; Naganawa S; Pietsch H
    Eur Radiol; 2017 Jul; 27(7):2877-2885. PubMed ID: 27832312
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The passage of 5 alpha-dihydrotestosterone from serum into cerebrospinal fluid and LH negative feedback in castrated rhesus monkeys.
    Abbott DH; Batty KA; Dubey AK; Herbert J; Shiers HM
    J Endocrinol; 1985 Mar; 104(3):325-30. PubMed ID: 3973526
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Investigation of interferon in the sera and cerebrospinal fluid of patients with Vogt-Koyanagi-Harada disease (author's transl)].
    Kato F; Ohno S; Matsuda H; Fujii N; Minagawa T
    Nippon Ganka Gakkai Zasshi; 1981 Mar; 85(3):217-21. PubMed ID: 6168187
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.